Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
323 studies found for:    female sexual dysfunction
Show Display Options
Rank Status Study
21 Unknown  Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%;   Drug: Topical study cream;   Drug: GRAS cream
22 Completed Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Condition: Systemic Sclerosis
Intervention: Drug: Cialis
23 Completed Topical Alprostadil for Female Sexual Arousal Disorder
Condition: Sexual Dysfunction, Physiological
Intervention: Drug: Topical alprostadil (PGE-1)
24 Completed Zestra in Women With Mixed Sexual Dysfunction
Condition: Sexual Dysfunction, Psychological
Intervention: Drug: Non-prescription Zestra(TM): patented formulation
25 Completed
Has Results
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
Conditions: Female Sexual Arousal Disorder;   Hypoactive Sexual Desire Disorder
Intervention: Drug: bremelanotide
26 Completed Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
Conditions: Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined);   Sexual Interest/Arousal Disorder (DSM-5 Defined)
Intervention: Drug: bupropion, Lorexys low-dose, Lorexys moderate-dose
27 Completed
Has Results
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Conditions: Breast Cancer;   Vaginal Dryness;   Dyspareunia;   Sexual Health Quality of Life
Intervention: Drug: Testosterone
28 Completed Female Sexual Function and Socioeconomic Status
Condition: Sexual Dysfunction
Intervention: Behavioral: assessment
29 Completed Female Orgasmic Disorder (FOD) and Wellbutrin XL
Condition: Orgasmic Disorder
Intervention: Drug: Wellbutrin XL
30 Unknown  Linguistic and Cultural Validation in Italian of Female Sexual Function Index (FSFI) Questionnaire
Condition: Sexual Dysfunction
31 Active, not recruiting A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Bremelanotide;   Drug: Placebo
32 Recruiting Physical Therapy as Adjuvant Treatment of Vulvodynia: a Randomized Controled Trial
Condition: Vulvodynia
Interventions: Drug: Amitriptyline;   Other: Kinesiotherapy;   Device: IC (Quark)
33 Completed Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women
Condition: Sex Behavior
Interventions: Drug: Biolipid B2 (blanked/placebo);   Drug: Testosterone, Transdermal, Behavior
34 Recruiting The Female Sexual Functions With Progestogen-only Contraception
Condition: Female Sexual Function
Interventions: Drug: Depot Medroxyprogesterone Acetate 150 mg;   Drug: Implanon( 68 mg etonogestrel implant);   Drug: Cerazette pills (75 micrograms desogestrel)
35 Completed Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder
Condition: Hypoactive Sexual Desire Disfunction
Interventions: Drug: tribulus terrestris;   Other: Placebo
36 Completed Testosterone in Female Hypoactive Sexual Desire Disorder
Condition: Hypoactive Sexual Desire Disorder
Intervention: Drug: testosterone gel (Androgel)
37 Recruiting Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Conditions: Painful Bladder Syndrome;   Interstitial Cystitis;   Pelvic Floor; Insufficiency;   Bowel Dysfunction;   Sexual Dysfunction;   Pelvic Floor; Incompetency
Intervention: Other: Changing the Interstim parameter of '' Frequency" in patients with Interstitial Cystitis
38 Recruiting Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women
Condition: Sexual Dysfunction, Physiological
Interventions: Behavioral: The Female Sexual Function Index (FSFI);   Behavioral: The Female Intervention Efficacy Index (FIEI);   Behavioral: The Beck Depression Inventory II;   Drug: Lepidium Meyenii Walp;   Drug: Placebo
39 Not yet recruiting Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule
Conditions: Menopause;   Dyspareunia
Intervention: Device: DESIRIAL® (Intra-mucosal Injections of Cross-linked Hyaluronic Acid)
40 Unknown  Sexual Dysfunction in Type 2 Diabetic Women
Conditions: Sexual Dysfunction;   Neuropathy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years